💉 Injection: Methotrexate Template

❓ Why is this important?

• Safe administration – with pre-dose checks, risks, consent, and safety steps documented

• Monitoring compliance – including FBC, LFTs, U&Es, infection status, and pregnancy exclusion

• Patient safety – through folic acid cover, counselling, and toxicity warnings

• Accurate coding – for audit and reimbursement

📊 High-level overview of the template structure

1. Pre-procedure checks – risks, consent, safety checks

2. Administration details – reason for methotrexate, site, route, needle size

3. Post-procedure documentation – outcome, advice, sharps disposal, Yellow Card if required

It also includes methotrexate-specific sections:

• Indication (RA, psoriasis, IBD, oncology, or other)

• Pre-dose checks (bloods, infection, pregnancy, interactions)

• Folic acid cover documented

• Patient counselling and safety reminders (weekly dosing, toxicity, alcohol, vaccination, leaflet)

📌 What do you need to know?

🧾 Local Enhanced Service (LES) Section

• Where a Local Enhanced Service exists, a dedicated section will appear automatically at the top of the template.

• This ensures correct coding and claiming for methotrexate injections.

• You do not need to use a separate LES template.

🛠️ Pre-procedure

• Risks discussed (pain, bleeding, infection, allergic reaction, fainting)

• Consent obtained and recorded

• Injection under PGD or PSD

• 6 safety checks completed

• Vaccine cold chain confirmed (if relevant)

💉 Administration

• Record indication for methotrexate (RA, psoriasis/psoriatic arthritis, IBD, oncology, or other)

• Route/site: SC upper arm, thigh, abdomen, or other

• Record needle size

• Confirm injection given and tolerated

✅ Post-procedure

• Outcome: no reaction, faintness, pain/swelling, allergic reaction

• Sharps disposed of safely

• Aftercare advice given

• Yellow Card submitted if adverse reaction suspected

💡 Hints and Tips

• Always check latest blood results before administration (FBC, LFTs, U&Es).

• Confirm no intercurrent infection and exclude pregnancy before dosing.

• Document folic acid cover at initiation and throughout therapy.

• Provide clear counselling on weekly-only dosing and toxicity symptoms.

• Use the LES section at the top of the template for coding and claiming (appears automatically).

• For long-term treatment, use recall/future actions to support monitoring schedules.

👉 See also:

• Generic Injection Template
  

• B12 Injection Template
  

• Denosumab Injection Template
  

• Hormone Injection Template
  

• Neuroleptic Depot Injection Template